SERUM INSTITUTE
MENFIVE
₹ 4,000 / Piece
No Charges till Medical Approval
MenFive: India Introduces the World’s First Pentavalent Meningococcal Conjugate Vaccine
India has launched MenFive, the world's first pentavalent meningococcal polysaccharide conjugate vaccine, developed by Serum Institute of India. The vaccine is designed to provide protection against five major meningococcal strains: A, C, Y, W, and X.
Key Highlights of MenFive
✅ WHO Prequalified and Registered in 10 Countries
✅ Single-Dose Vaccine for active immunization against invasive meningococcal disease
✅ Recommended for Individuals Aged 18-85 Years, especially:
- Students, workers, and travelers to Saudi Arabia and other meningitis-endemic regions
- Hajj and Umrah pilgrims, where meningococcal vaccination is mandatory
Global Recognition
🔹 Nigeria was the first country to roll out MenFive (Men5CV), recommended by the World Health Organization (WHO).
🔹 Experts from Gavi, The Vaccine Alliance, emphasize its importance in fighting the growing threat of infectious diseases worldwide.
This groundbreaking vaccine marks a significant milestone in preventing meningococcal disease, ensuring broader protection against multiple strains in a single dose.
For more details, visit Serum Institute of India.
Prescription Compulsory
| Painless (gentle) | NO |
| Imported | NO |
| Doses | 1 |
| Antigens | 5 |
| Vaccine Type | Inactivated |
| Pregnancy | No |
| Lactation | No |
| >2 Yr age | No |
| Boosters | No |
| ACVIP 2020 Guidelines | No |
| >9 month to any age | No |
| Adult vaccine | Yes- 18-65yrs |
MenFive: India Introduces the World’s First Pentavalent Meningococcal Conjugate Vaccine
India has launched MenFive, the world's first pentavalent meningococcal polysaccharide conjugate vaccine, developed by Serum Institute of India. The vaccine is designed to provide protection against five major meningococcal strains: A, C, Y, W, and X.
Key Highlights of MenFive
✅ WHO Prequalified and Registered in 10 Countries
✅ Single-Dose Vaccine for active immunization against invasive meningococcal disease
✅ Recommended for Individuals Aged 18-85 Years, especially:
- Students, workers, and travelers to Saudi Arabia and other meningitis-endemic regions
- Hajj and Umrah pilgrims, where meningococcal vaccination is mandatory
Global Recognition
🔹 Nigeria was the first country to roll out MenFive (Men5CV), recommended by the World Health Organization (WHO).
🔹 Experts from Gavi, The Vaccine Alliance, emphasize its importance in fighting the growing threat of infectious diseases worldwide.
This groundbreaking vaccine marks a significant milestone in preventing meningococcal disease, ensuring broader protection against multiple strains in a single dose.
For more details, visit Serum Institute of India.
Reviews and Ratings
No Customer Reviews
Share your thoughts with other customers
